Medtech 360

October 2013

US Markets for Physician-Dispensed Cosmeceuticals 2014


Physician-dispensed cosmeceuticals can be used in stand-alone treatments or in combination with other aesthetic treatments to yield improved results; the market for these products continues to experience strong growth due to high demand from aesthetically conscious patients.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for physician-dispensed cosmeceuticals in the US across a 10-year period.

We have up-to-date reports on a wide range of medical device markets worldwide.

Questions Answered in This Report:

  *  Favorable demographics and a greater number of physicians carrying more products will drive strong growth in the physician-dispensed cosmeceutical market in the US.

What types of patients are purchasing cosmeceutical products and why?

Which physician specialties are adopting physician-dispensed cosmeceuticals into their practices?

What kinds of factors are limiting growth of the market?

  *   The antiaging product market, which includes antiwrinkle and pigment control cosmeceutical products, is the largest physician-dispensed cosmeceutical segment and will be a fast-growing market through 2022.

Why is the antiaging market growing faster than some of the other product segments?

Within the antiaging product market, which segment has the most potential for revenue growth?

In contrast to the antiaging product segment, which of the physician-dispensed cosmeceutical markets is the smallest and why?

  *   The market is dominated by large multinational manufacturers that also have other aesthetic products, and recent consolidation in the market will likely increase competition.

Which companies are the leading competitors in the US physician-dispensed cosmeceutical market?

What strategies are competitors employing to maintain their competitive advantage?

Which competitors are most poised to improve their market shares in the next few years?


Geographies Covered: US

Products Covered: Our analysis uses the following breakdown of products in the market:

Product Type

Antiaging Products



Area of the Face


Active Ingredient*


Hydroxy Acids



Growth Factors




Pigment Control

Active Ingredient



Acne Treatment Products

Product Type



Creams or Lotions

Targeted Complexes or Spot Treatments

Medicated Pads

Sun Protection Products

Active Ingredient




Preparation Cosmeceuticals

Product Type



Hydrating Moisturizers

Chemical Peels

(1) *Discussed qualitatively only. (2) **Cleansers include basic cleansers and exfoliators.

Market Forecast Features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in unit sales, ASPs, and market values over a 10-year period (2012–2022).

Competitive Analysis: We provide a detailed analysis of the competitive landscape and market shares for leading competitors.


Carmen Chan

April Chan
Karen Gierszewski
Nancy Huynh
Samuli Heilala, M.Sc.
Veronica Ross
Jackie Tang, M.A.

Search Reports

Mentioned in this report:

  • Allergan
  • Astral Brands
  • Axia Medical Solutions
  • Beaute Pacifique
  • Biopelle
  • Colorescience
  • CosMedical Technologies
  • Cynergy
  • DCL
  • DermaQuest
  • EltaMD
  • Environ
  • Envy Medical
  • Episciences
  • Fallene Cosmeceuticals
  • gloProfessional
  • GlyMed Plus
  • G.M. Collin
  • Histogen
  • Image Skincare
  • Innovative Skincare
  • Jan Marini
  • Johnson & Johnson
  • Laboratoires Pierre Fabre
  • Laboratoires TEOXANE
  • Lifeline Skin Care
  • L'Oréal
  • MDSolarSciences
  • Medicis
  • Merz Pharma
  • mesoestetic
  • mybody
  • Neocutis
  • NeoStrata
  • Niadyne Pharma
  • Obagi Medical Products
  • PhotoMedex
  • Revision Skincare
  • SkinCeuticals
  • SkinMedica
  • Stiefel Laboratories
  • Syneron
  • Topix Pharmaceuticals
  • US CosmeceuTechs
  • Valeant Pharmaceuticals International
  • Vivier Pharma
  • ZO Skin Health
Decision Resources Group brands include: